Role of G2-S16 Polyanionic Carbosilane Dendrimer in the Prevention of Respiratory Syncytial Virus Infection In Vitro and In Vivo in Mice
Ignacio Rodriguez-Izquierdo,
Rafael Ceña-Diez,
Maria Jesús Serramia,
Rosa Rodriguez-Fernández,
Isidoro Martínez,
Mariángeles Muñoz-Fernández
Affiliations
Ignacio Rodriguez-Izquierdo
Immunology Section, Head Inmuno-Biology Molecular Laboratory, Gregorio Marañón University General Hospital (HGUGM), Gregorio Marañón Health Research Institute (IiSGM), 28007 Madrid, Spain
Rafael Ceña-Diez
Immunology Section, Head Inmuno-Biology Molecular Laboratory, Gregorio Marañón University General Hospital (HGUGM), Gregorio Marañón Health Research Institute (IiSGM), 28007 Madrid, Spain
Maria Jesús Serramia
Immunology Section, Head Inmuno-Biology Molecular Laboratory, Gregorio Marañón University General Hospital (HGUGM), Gregorio Marañón Health Research Institute (IiSGM), 28007 Madrid, Spain
Rosa Rodriguez-Fernández
Hospital de Pediatría, Gregorio Marañón University General Hospital (HGUGM), Gregorio Marañón Health Research Institute (IiSGM), C/Dr. Esquerdo 46, 28007 Madrid, Spain
Isidoro Martínez
Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28007 Madrid, Spain
Mariángeles Muñoz-Fernández
Immunology Section, Head Inmuno-Biology Molecular Laboratory, Gregorio Marañón University General Hospital (HGUGM), Gregorio Marañón Health Research Institute (IiSGM), 28007 Madrid, Spain
The respiratory syncytial virus (RSV) causes respiratory infection and bronchiolitis, requiring hospitalization mainly in infants. The interaction between RSV, envelope glycoproteins G and F, and cell surface heparan sulfate proteoglycans (HSPG) is required for binding and entry into the host cells. A G2-S16 polyanionic carbosilane dendrimer was identified as a possible RSV inhibitor. We speculated that the G2-S16 dendrimer adheres to the host cell-surface HSPG, acts through binding to HS receptors, and prevents further RSV infection. The G2-S16 dendrimer was non-toxic when applied intranasally to Balb/c mice, and interestingly enough, this G2-S16 dendrimer inhibits 85% RSV. Therefore, our G2-S16 dendrimer could be a candidate for developing a new possible therapy against RSV infection.